Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.19 USD
Change Today -0.009 / -4.62%
Volume 260.0K
HEB On Other Exchanges
As of 8:04 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - hemispherx biopharma inc (HEB)

NameBoard RelationshipsTitleAge
William A. Carter M.D.6 RelationshipsChairman, Chief Executive Officer, President, Chief Scientific Officer, Chairman of Executive Committee, Member of Strategic Planning Committee and Member of Disclosure Controls Committee77
Thomas K. Equels Esq.6 RelationshipsExecutive Vice Chairman, Chief Financial Officer, General Counsel, Secretary, Member of Executive Committee, Member of Disclosure Controls Committee and Member of Strategic Planning Committee61
Wayne S. Springate No RelationshipsSenior Vice President of Operations and Chairman of Disclosure Controls Committee44
David R. Strayer M.D.No RelationshipsChief Medical Officer and Medical Director69

Board Members - hemispherx biopharma inc (HEB)

NameBoard RelationshipsPrimary CompanyAge
William A. Carter M.D.6 RelationshipsHemispherx Biopharma, Inc.77
Thomas K. Equels Esq.6 RelationshipsHemispherx Biopharma, Inc.61
William M. Mitchell M.D., Ph.D.13 RelationshipsHemispherx Biopharma, Inc.80
Iraj Eqhbal Kiani MBA, N.D., Ph.D.6 RelationshipsHemispherx Biopharma, Inc.69
Peter W. Rodino III, Esq.6 RelationshipsHemispherx Biopharma, Inc.64

Executive Committees* - hemispherx biopharma inc (HEB)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteePeter W. Rodino III, Esq. 6 Relationships3 Executives
Compensation CommitteeIraj Eqhbal Kiani MBA, N.D., Ph.D. 6 Relationships3 Executives
Nominating CommitteeWilliam M. Mitchell M.D., Ph.D. 13 Relationships3 Executives
Corporate Governance CommitteeWilliam M. Mitchell M.D., Ph.D. 13 Relationships3 Executives
Executive CommitteeWilliam A. Carter M.D. 6 Relationships3 Executives
View HEB Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HEB:US $0.19 USD -0.009

HEB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Allergan plc $334.92 USD +3.77
AstraZeneca PLC 4,342 GBp +22.00
Baxter International Inc $39.51 USD -0.57
Medigene AG €10.23 EUR +0.48
Sarepta Therapeutics Inc $33.50 USD +1.58
View Industry Companies

Industry Analysis


Industry Average

Valuation HEB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 265.3x
Price/Book 1.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 180.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEMISPHERX BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at